Korea BioNews
Total 367 Article , currentpage 21 /Total Page RSS
| No | SUBJECT | SOURCE | DATE | COUNT |
|---|---|---|---|---|
| 167 | AMC Cancer Institute pioneers multidisciplinary cancer treatment | Pulse | 2023-11-27 | 5 |
| 166 | PeproMene Bio unveils positive phase 1 data | Pulse | 2023-11-27 | 7 |
| 165 | VUNO wins FDA approval for AI-based brain imaging analysis medical device | Pulse | 2023-11-27 | 6 |
| 164 | Korean researcher develops treatment targeting cancer cells using nitric oxide | Pulse | 2023-11-27 | 6 |
| 163 | Celltrion's new autoimmune disease treatment wins FDA approval | Yonhap News Agency | 2023-11-27 | 5 |
| 162 | S. Korea in final stages to acquire homegrown anthrax vaccine | Yonhap News Agency | 2023-11-27 | 5 |
| 161 | Diabetes medicine Tirzepatide outperforms Semaglutide | Pulse | 2023-11-23 | 8 |
| 160 | Korean biotechs actively apply nanotechnology to therapeutics | Pulse | 2023-11-23 | 6 |
| 159 | HLB on a quest for next-generation target cancer therapy CAR-T: CEO interview | Pulse | 2023-11-23 | 6 |
| 158 | Daewoong Pharm’s botox Nabota granted U.S. patent for migraine treatment | Pulse | 2023-11-23 | 4 |